Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Commercial

Set Alert for Commercial

Diabetes, Mitral Repair And Diagnostics Drive Big Quarter For Abbott

Abbott Laboratories’ medical device businesses grew 10.6% year over year in the third quarter of 2019 while its diagnostics business grew 6.6%, helping the company grow 7.6% overall, the company reported on 16 October.

Commercial Sales & Earnings Diabetic Care
Advertisement

Companies

Set Alert for Companies

Latest From Companies

Pentax Medical Pushes People, Product And Process Amid New US FDA Guidance

With the US FDA urging providers to transition away from fixed duodenoscopes to newer designs that reduce or eliminate reprocessing of the device, Pentax Medical is seizing an opportunity to increase supply of its disposable cap scope. Medtech Insight talks to the company’s global clinical officer, Garrett Hudson, on the challenges of endoscopy hygiene and the company’s response to guidance.

FDA Gastroenterology

Qiagen In Crisis, Previews Poor Q3 Sales; Long-Term CEO Steps Down

Qiagen shares took a hit following a series of negative announcements, including lower than expected results for Q3 2019 and the departure of long-term CEO Peer Schatz. The company said it had been affected by poor sales growth in China.

Sales & Earnings In Vitro Diagnostics

Accelmed Launches New $100M Venture Medtech Fund

Israeli healthtech fund Accelmed is raising $100m for its fourth fund focused on medical device and digital health companies.

 

Digital Health Commercial
See All

Deals and Financings

Set Alert for Deals

Latest From Deals

QUOTED. 16 October 2019. John Sheridan.

Abbott signed a deal with Tandem Diabetes Care to develop diabetes solutions combining Abbott's glucose-sensing technology with Tandem's insulin delivery systems. See what Tandem's CEO and president, John Sheridan, said about the partnership here.

Quoted Diabetic Care

Abbott Inks Partnership With Tandem Diabetes Care

Abbott signed a deal with Tandem Diabetes Care to develop diabetes solutions to combine Abbott's glucose-sensing technology with Tandem's insulin delivery systems.

Diabetic Care Commercial

Abbott Signs Partnership With Omada To Expand FreeStyle Libre Users

Abbott signed a deal with Omada Health to integrate Abbott's FreeStyle Libre with Omada's health coaching platform.

Commercial Deals
See All

Market Access

Set Alert for Market Access

Latest From Market Access

UK IVDs Broach Brexit Preparedness In Case Of No-Deal EU Exit

With the current Brexit date less than a month away, the UK IVDs industry is busy providing support to UK manufacturers and the pathology sector in an attempt to ensure no one gets caught out. Coinciding with this are the ongoing preparations for the EU IVDR, and a raft of UK-specific issues for the diagnostics industry.          

United Kingdom Medical Device

Australia Reviews Ban On Many Self-Testing IVDs

A new public consultation is looking at whether Australia’s rules prohibiting the supply of many types of self-testing IVDs are still fit for purpose.

In Vitro Diagnostics Australia

Market Brief: Global Fracture Fixation Market To Hit $10.8Bn By 2023

The global market for fracture fixation products is expected to reach nearly $10.8bn by 2023, a CAGR of 5.9%. Internal fixation devices for small-bone fractures are expected to see the largest growth over the forecast period, according to a new analysis by Meddevicetracker.

Orthopedics Surgery
See All

Market Intelligence

Set Alert for Market Intelligence

Latest From Market Intelligence

Market Intel: 3D Bioprinting Forges Ahead With Mini Human Heart, Human Tissue

The race continues to heat up in the bioprinting space over which players will first reach the finish line in gaining approval for tissue and organ replacements. Research organizations and companies worldwide are in various states of development for these milestones in regenerative medicine, ranging from bioprinting skin to a mini human heart. But regulatory hurdles and quality testing could be formidable.

Market Intelligence Innovation

Market Brief: Global Fracture Fixation Market To Hit $10.8Bn By 2023

The global market for fracture fixation products is expected to reach nearly $10.8bn by 2023, a CAGR of 5.9%. Internal fixation devices for small-bone fractures are expected to see the largest growth over the forecast period, according to a new analysis by Meddevicetracker.

Orthopedics Surgery

QUOTED. 21 August 2019. David Smith.

The largest diagnostics companies, including Roche Diagnostics Corp., showcased their latest products at the recent American Association for Clinical Chemistry's (AACC) conference in Anaheim. See what David Smith, regional business manager for Roche's Navify decision-support portfolio, said about it here.

Quoted Market Intelligence
See All

Appointments

Set Alert for Appointments

Latest From Appointments

Execs On The Move: An Exit And A Promotion For Chief Officers At Qiagen And Halma

CEO of molecular diagnostics firm Qiagen steps down after decades of service; Halma division chief steps up to medical and environmental sector chief exec; and more.

Appointments Commercial

Execs On The Move: Advisors Ascend At Angel Medical And Endonovo

Angel Medical Systems, makers of an implantable cardiac monitoring system, has assembled a medical advisory board; electroceutical therapy firm Endonovo Therapeutics has hired a strategic adviser as its CEO; and more.

Appointments Commercial

Execs On The Move: BD Unveils CEO Succession Plan; CSO Joins Oncimmune From AZ

AstraZeneca’s chief scientist moved over to cancer diagnostics firm Oncimmune; JenaValve, developer of a heart valve replacement system, hired a new VP of operations; Becton Dickinson & Co. has moved forward with a CEO succession plan; and more.

Appointments Commercial
See All
UsernamePublicRestriction

Register

Advertisement